Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2026-01-06 @ 8:06 AM
Study NCT ID:
NCT03123094
Status:
COMPLETED
Last Update Posted:
2024-03-06
First Post:
2017-04-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male Subjects
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-04
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-13
First Submit QC Date:
None
Study First Post Date:
2017-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-26
Results First Submit QC Date:
None
Results First Post Date:
2024-03-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-11
Last Update Post Date:
2024-03-06
Last Update Post Date Type:
ACTUAL